Delays in Core Laboratory Testing, Tuesday, December 13, 2016

On Tuesday, December 13, 2016, instrumentation in the core clinical laboratory will be impacted by construction project.  The following assays will be delayed from approximately 0000 to 1800:

Alpha 1 Antitrypsin (LAB927)
Angiotensin - 1 Converting Enzyme (LAB563)
Amikacin Drug Level (LAB555)
Beta-2 Microglobulin (LAB49)
Bile Acids, Total (LAB2713)
C3 Complement (LAB152)
C4 Complement (LAB151)
Carbamazepine Drug Level (LAB22)
Cardiac CRP (LAB150)
Ceruloplasmin (LAB582)
Cystatin C (LAB2967)
Ethylene Glycol, Plasma (LAB7453)
Everolimus Drug Level (LAB7456)
Folate (Folic Acid) (LAB69)
Homocysteine (LAB93)
Keppra (Levetriracetam) Drug Level (LAB477)
Lamotrigine (Lamictal) Drug Level (LAB475)
Lidocaine Drug Level (LAB641)
Myoglobin (LAB105)
Myoglobin, Urine (LAB8102)
Pentobarbital Drug Level (LAB656)
Phenytoin Free Drug Level (LAB32)
Phenobarbital Drug Level (LAB30)
Rheumatoid Factor (LAB206)
Soluble Transferrin Receptor (LAB906)
Nicotine Metabolite, Rapid Screen (LAB8071)
Valproic Acid Drug Level (LAB25)

Please contact Specimen Control (356-3527) for more information on specific assays.

Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry Laboratory (384-9380,